| Senile systemic amyloidosis | |
|---|---|
| Classification and external resources | |
| ICD-9 | 277.3 |
| OMIM | 176300 |
| eMedicine | med/3365 |
Senile systemic amyloidosis is a form of amyloidosis associated with transthyretin.[1]
It is estimated to affect a quarter of the population over 85 years of age.[2]
References
- ^ Westermark P, Sletten K, Johansson B, Cornwell GG (April 1990). "Fibril in senile systemic amyloidosis is derived from normal transthyretin". Proc. Natl. Acad. Sci. U.S.A. 87 (7): 2843–5. doi:. PMID 2320592. PMC 53787. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=2320592.
- ^ Tanskanen M, Peuralinna T, Polvikoski T, et al. (2008). "Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study". Ann. Med. 40 (3): 232–9. doi:. PMID 18382889. http://www.informaworld.com/openurl?genre=article&doi=10.1080/07853890701842988&magic=pubmed.
--External Links==
|
|||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
